- Report
- November 2024
- 109 Pages
Global
From €3500EUR$4,212USD£3,130GBP
- Report
- April 2024
- 91 Pages
Global
From €3500EUR$4,212USD£3,130GBP
- Report
- October 2023
- 108 Pages
Global
From €3500EUR$4,212USD£3,130GBP
- Report
- August 2023
- 110 Pages
Global
From €3500EUR$4,212USD£3,130GBP
- Report
- August 2022
- 84 Pages
Global
From €3500EUR$4,212USD£3,130GBP
- Report
- July 2024
- 132 Pages
Global
From €846EUR$950USD£731GBP
- Report
- April 2024
- 132 Pages
Global
From €846EUR$950USD£731GBP
The Swine Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and production of vaccines for swine. Vaccines are used to protect swine from a variety of diseases, including Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus (PCV), and Classical Swine Fever (CSF). Vaccines are typically administered to swine through injection or oral administration.
The Swine Vaccine market is highly competitive, with a number of companies offering a variety of products. Companies in the market include Merck Animal Health, Zoetis, Elanco, Boehringer Ingelheim, and Ceva Sante Animale. These companies offer a range of products, including vaccines for PRRS, PCV, and CSF, as well as other vaccines for swine. Show Less Read more